当前位置： 易推广 > 生物试剂/抗体/细胞 > 生化试剂 > 其他 > 继圣（上海）医疗器械有限公司 > 产品展示 > 徕卡CA19-9 (Sialyl Lewisa)
徕卡CA19-9 (Sialyl Lewisa)
价格：￥电议
品牌名称：$brandModel.Title(进口品牌)型号： 原产地：中国大陆 发布时间：2022/5/12 20:35:58更新时间：2024/8/28 10:38:41
产品摘要：Sialylated Lewisa plays a role in cell adhesion by acting as a functional ligandfor the inducible adhesion molecule E-selectin.
产品完善度： 访问次数：153
企业档案
会员类型：会员
已获得易推广信誉 等级评定
41成长值
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：4年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：经销商 【已认证】
注册资金：人民币万 【已认证】
产品数：3388
参观次数：704125
详细内容
徕卡CA19-9 (Sialyl Lewisa)
Clone C241:5:1:4
7 mL BOND ready-to-use PA0424 P (HIER)
Antigen Background
CA19-9 is an epitope on the sialylated Lewisa carbohydrate structure.
Sialylated Lewisa plays a role in cell adhesion by acting as a functional ligand
for the inducible adhesion molecule E-selectin. CA19-9 ａnd CA50 (carcinoma
associated mucin antigen) are useful serum markers in the diagnosis and
follow up of gastrointestinal ａnd pancreatic cancers. In carcinoma of the
pancreas, it is reported that the immunohistochemical expression of both
CA19-9 ａnd CA50 correlates with tumor differentiation where the strongest
staining is observed in well differentiated tumors. These two markers are also
reported in a number of benign lesions such as chronic pancreatitis.
Also available as a liquid concentrate, refer to page 101
Adenocarcinoma: immunohistochemical staining with BOND ready-to-use CA19-9 (Sialyl
Lewisa) (C241:5:1:4) using BOND Polymer Refine Detection.
Clone C241:5:1:4
7 mL BOND ready-to-use PA0424 P (HIER)
Antigen Background
CA19-9 is an epitope on the sialylated Lewisa carbohydrate structure.
Sialylated Lewisa plays a role in cell adhesion by acting as a functional ligand
for the inducible adhesion molecule E-selectin. CA19-9 ａnd CA50 (carcinoma
associated mucin antigen) are useful serum markers in the diagnosis and
follow up of gastrointestinal ａnd pancreatic cancers. In carcinoma of the
pancreas, it is reported that the immunohistochemical expression of both
CA19-9 ａnd CA50 correlates with tumor differentiation where the strongest
staining is observed in well differentiated tumors. These two markers are also
reported in a number of benign lesions such as chronic pancreatitis.
Also available as a liquid concentrate, refer to page 101
Adenocarcinoma: immunohistochemical staining with BOND ready-to-use CA19-9 (Sialyl
Lewisa) (C241:5:1:4) using BOND Polymer Refine Detection.
